SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE CHARACTERISTICS ASSOCIATED WITH THE TYPE I INTERFERON GENE SIGNATURE: BASELINE DATA OF THE SLE PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)

被引：0
|
作者：
Hammond, Edward R. [1 ]
Aringer, Martin [2 ,3 ]
Arnaud, Laurent [4 ]
Peschken, Christine [5 ]
Knagenhjelm, Jacob [6 ]
Barut, Volkan [7 ]
Wang, Xia [1 ]
Desta, Barnabas [1 ]
Tummala, Raj [1 ]
Ginkel, David [1 ]
Furie, Richard [8 ]
Morand, Eric F. [9 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Tech Univ Dresden, Univ Med Ctr, Dresden, Germany
[3] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany
[4] Univ Strasbourg, Ctr Natl Reference Malad Autoimmunes & Syst Rares, Serv Rhumatol, INSERM,UMR S 1109, Strasbourg, France
[5] Univ Manitoba, Dept Med & Community Hlth Sci, Winnipeg, MB, Canada
[6] AstraZeneca, Gothenburg, Sweden
[7] AstraZeneca, Cambridge, England
[8] Hofstra Northwell Sch Med, New York, NY USA
[9] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3382
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0128
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] Systemic lupus erythematosus (SLE) disease characteristics associated with the type I interferon gene signature: Baseline data of the SLE prospective observational cohort study (SPOCS)
    Hammond, Edward R.
    Aringer, Martin
    Arnaud, Laurent
    Peschken, Christine
    Knagenhjelm, Jacob
    Barut, Volkan
    Wang, Xia
    Desta, Barnabas
    Tummala, Raj
    Ginkel, David
    Furie, Richard
    Morand, Eric F.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 493 - 493
  • [2] Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature
    Arnaud, Laurent
    Furie, Richard
    Morand, Eric F.
    Aringer, Martin
    Peschken, Christine
    Desta, Barnabas
    Rapsomaniki, Eleni
    Hedberg, Jonatan
    Knagenhjelm, Jacob
    Seo, Caroline
    Een, Tina Gruenfeld
    Sorrentino, Alessandro
    Tummala, Raj
    Stirnadel-Farrant, Heide A.
    Ding, Bo
    [J]. LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
  • [3] Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature
    Hammond, Edward R.
    Tummala, Raj
    Berglind, Anna
    Syed, Farhat
    Wang, Xia
    Desta, Barnabas
    Nab, Henk
    [J]. BMJ OPEN, 2020, 10 (09):
  • [4] Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Morand, Eric
    Furie, Richard
    Peschken, Christine
    Aringer, Martin
    Arnaud, Laurent
    Desta, Barnabas
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Chen, Stephanie
    Ding, Bo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4484 - 4486
  • [5] ASSOCIATION OF PATIENT-REPORTED OUTCOMES WITH TYPE I INTERFERON GENE SIGNATURE FROM THE INTERNATIONAL SYSTEMIC LUPUS ERYTHEMATOSUS PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)
    Aringer, M.
    Arnaud, L.
    Peschken, C.
    Furie, R.
    Morand, E. F.
    Seo, C.
    Rapsomaniki, E.
    Hedberg, J.
    Knagenhjelm, J.
    Een, T. Grunfeld
    Desta, B.
    Tummala, R.
    Sorrentino, A.
    Stirnadel-Farrant, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 648 - 649
  • [6] Organ Damage Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Furie, Richard
    Morand, Eric
    Peschken, Christine
    Aringer, Martin
    Arnaud, Laurent
    Desta, Barnabas
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Chen, Stephanie
    Ding, Bo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4552 - 4554
  • [7] Real-World Treatment Patterns in Patients with Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Aringer, Martin
    Arnaud, Laurent
    Furie, Richard A.
    Morand, Eric
    Peschken, Christine
    Desta, Barnabas
    Rapsomaniki, Eleni
    Hedberg, Jonatan
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Ghia, Canna
    Chen, Stephanie
    Ding, Bo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1172 - 1174
  • [8] Type I Interferon Signature in Systemic Lupus Erythematosus
    Bezalel, Shira
    Guri, Keren Mahlab
    Elbirt, Daniel
    Asher, Ilan
    Sthoeger, Zev Moshe
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (04): : 246 - 249
  • [9] Longitudinal prospective study of Type I Interferon pathway activation as a biomarker of disease activity in patients with systemic lupus erythematosus(SLE) - Interim analysis
    Barillas-Arias, Lilliana
    MacDermott, Emma Jane
    Duculan, Roland
    Santiago, Annie
    Gordon, Eric
    Cole, Pamela
    Crow, Mary K.
    Kirou, Kyriakos A.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4245 - 4245
  • [10] Longitudinal prospective study of Type I Interferon pathway activation as a biomarker of disease activity in patients with Systemic Lupus Erythematosus (SLE): Interim analysis
    Barillas-Arias, L.
    MacDermott, E. -J.
    Duculan, R.
    Santiago, A.
    Gordon, E.
    Cole, P.
    Crow, M. K.
    Kirou, K. A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S565 - S566
12345